Public-domain · open source
OpenJurist
← 886 F. Supp. 2d 497 - Carlucci v. Han

886 F. Supp. 2d 497 - Carlucci v. Han’s Empirical Analysis

2012

Citation profile

8
cited by 8 later decisions
September 2018
most recently cited

2 district ·

Relationships

Applies 15 U.S.C. § 77K (§ 11 of the Securities Act of 1933) · 15 U.S.C. § 78C (§ 3 of the Securities Exchange Act of 1934) · 15 U.S.C. § 78J (§ 10 of the Securities Exchange Act of 1934) · 15 U.S.C. § 78U (§ 21 of the Securities Exchange Act of 1934) · 15 U.S.C. § 78U (§ 21d of the Securities Exchange Act of 1934) · 15 U.S.C. § 78U (§ 21e of the Securities Exchange Act of 1934) · 28 U.S.C. § 1331 · 28 U.S.C. § 1332 (Class Action Fairness Act of 2005)

Relies on Bell Atlantic Corp. v. Twombly · Ashcroft v. Iqbal · Klaxon Co. v. Stentor Electric Manufacturing Co. · Ernst & Ernst v. Hochfelder · Tellabs, Inc. v. Makor Issues & Rights, Ltd.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 8 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “a certain kind of rosy affirmation commonly heard from corporate managers and familiar to the marketplace — loosely optimistic statements that are so vague, so lacking in specificity, or so clearly constituting the opinions of the speaker, that no reasonable investor could find them important to the total mix of information available.”
    1 later decision quote this exact passage · from the majority
  2. “Indefinite statements of corporate optimism, also known as puffery, are generally non-actionable, as they do not demonstrate falsity.”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.